Who are CAIVT 10^5's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Post - Vaccination, ROTAVAC 5C -F1, hepatitis A inactivated virus vaccine, IMOVAX Polio®.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/caivt-10-5.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

CAIVT 10^5 — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

CAIVT 10^5 (CAIVT 10^5) competitive landscape: 4 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Virus vaccine. Area: Respiratory.

phase 2 Virus vaccine Respiratory Biologic Live · refreshed every 30 min

Target snapshot

CAIVT 10^5 (CAIVT 10^5) — MedImmune LLC. CAIVT 10^5 is a live attenuated virus vaccine.

Comparator set (4 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
CAIVT 10^5 TARGET	CAIVT 10^5	MedImmune LLC	phase 2	Virus vaccine
Post - Vaccination	vaccination	Pfizer	marketed	Inactivated Poliovirus Vaccine [EPC]	Immune system
ROTAVAC 5C -F1	ROTAVAC 5C -F1	Bharat Biotech International Limited	phase 3	Live attenuated rotavirus vaccine
hepatitis A inactivated virus vaccine	hepatitis A inactivated virus vaccine	GlaxoSmithKline	phase 3	inactivated virus vaccine
IMOVAX Polio®	IMOVAX Polio®	GlaxoSmithKline	phase 3	Inactivated poliovirus vaccine (IPV)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Virus vaccine class)

MedImmune LLC · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). CAIVT 10^5 — Competitive Intelligence Brief. https://druglandscape.com/ci/caivt-10-5. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing